Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 3 years.
BioCryst Pharmaceuticals Inc.
Director
Fortrea Holdings Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Fortrea Holdings Inc. | Open-market sale | −9,700 | $18.01 | $174,697 |
| Jun 11, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +15,294 | — | — |
| Jun 10, 2026 | Fortrea Holdings Inc. | Option exercise | +38,817 | — | — |
| Nov 13, 2025 | BioCryst Pharmaceuticals Inc. | Open-market sale | −9,600 | $7.14 | $68,544 |
| Jun 12, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +12,500 | — | — |
| May 14, 2025 | Fortrea Holdings Inc. | Option exercise | +7,282 | — | — |
| Jun 17, 2024 | BioCryst Pharmaceuticals Inc. | Open-market sale | −4,689 | $6.00 | $28,134 |
| Jun 12, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +6,820 | — | — |
| Jun 15, 2023 | BioCryst Pharmaceuticals Inc. | Open-market sale | −4,000 | $7.98 | $31,920 |
| Jun 13, 2023 | BioCryst Pharmaceuticals Inc. | Grant or award | +16,745 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.